Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ark Genomic Revolution Multi-Sector ETF (ARKG)

Ark Genomic Revolution Multi-Sector ETF (ARKG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Ark Funds
  • Assets Under Management 502,959,600
  • Market Capitalization, $K 502,960
  • Shares Outstanding, K 14,655
  • 60-Month Beta 1.96
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 1.05 (3.13%)
  • Most Recent Dividend 1.054 on 12/27/19
  • Management Fee 0.75%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.22 +4.59%
on 01/06/20
36.63 -8.00%
on 12/26/19
-2.73 (-7.49%)
since 12/24/19
3-Month
28.01 +20.31%
on 10/25/19
36.63 -8.00%
on 12/26/19
+5.24 (+18.41%)
since 10/24/19
52-Week
26.87 +25.42%
on 01/29/19
36.63 -8.00%
on 12/26/19
+6.02 (+21.75%)
since 01/24/19

Most Recent Stories

More News
Why Biotech ETFs are Surging to New Highs

increasing M&A deals and cutting edge therapies are driving biotech ETFs higher

MRK : 85.98 (-2.91%)
SNY : 48.73 (-1.75%)
NVS : 93.87 (-1.11%)
IBB : 116.88 (-2.19%)
BBC : 36.36 (-3.55%)
SBIO : 40.08 (-2.53%)
XBI : 90.75 (-2.69%)
THOR : 67.99 (unch)
MDCO : 84.90 (-0.07%)
ARQL : 20.00 (+0.15%)
AUPH : 18.95 (-0.42%)
ARKG : 33.70 (-1.92%)
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 40.08 (-2.53%)
BBP : 41.88 (-2.24%)
BTEC : 38.91 (+0.07%)
BBH : 135.76 (-1.79%)
XBI : 90.75 (-2.69%)
IBB : 116.88 (-2.19%)
FBT : 145.47 (-2.02%)
CNCR : 22.13 (-2.47%)
PBE : 55.56 (-2.30%)
ARKG : 33.70 (-1.92%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 22.13 (-2.47%)
BBC : 36.36 (-3.55%)
BBP : 41.88 (-2.24%)
GBT : 73.13 (-8.29%)
PTI : 1.75 (-6.42%)
VRTX : 229.06 (-2.07%)
CLVS : 8.93 (-3.04%)
MYOV : 12.96 (-3.28%)
CNST : 36.61 (+0.52%)
KRTX : 99.75 (unch)
CRSP : 54.75 (-3.22%)
ARKG : 33.70 (-1.92%)
GNOM : 15.20 (-1.61%)
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

GLD : 147.98 (+0.58%)
ALNY : 120.00 (+1.73%)
GBT : 73.13 (-8.29%)
CRSP : 54.75 (-3.22%)
ARKG : 33.70 (-1.92%)
Why Gold is Headed to Zero -- And What You Should Buy Instead

Why Gold is Headed to Zero -- And What You Should Buy Instead

TSLA : 564.82 (-1.29%)
IBB : 116.88 (-2.19%)
GLD : 147.98 (+0.58%)
GBT : 73.13 (-8.29%)
CRSP : 54.75 (-3.22%)
ARKG : 33.70 (-1.92%)
ALNY : 120.00 (+1.73%)
Genomics ETFs Surge on CRISPR's Gene Editing Progress

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

PBE : 55.56 (-2.30%)
VRTX : 229.06 (-2.07%)
CRSP : 54.75 (-3.22%)
ARKG : 33.70 (-1.92%)
IDNA : 28.74 (-1.88%)
GNOM : 15.20 (-1.61%)
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

PTH : 92.61 (-2.45%)
PBE : 55.56 (-2.30%)
XBI : 90.75 (-2.69%)
CNCR : 22.13 (-2.47%)
DXCM : 233.94 (-0.70%)
CLVS : 8.93 (-3.04%)
BIIB : 278.14 (-2.14%)
PTI : 1.75 (-6.42%)
AQST : 3.88 (-2.27%)
FTSV : 39.03 (-10.58%)
ARKG : 33.70 (-1.92%)
S&P 500 at Record High: 6 ETF Winners of Last Week

The S&P 500 hit record highs last week, with the index rising for the fourth consecutive week, marking its longest winning streak since March.

PRNT : 22.94 (-0.48%)
XSD : 110.34 (-1.94%)
BBC : 36.36 (-3.55%)
VETS : 32.76 (-0.81%)
LEND : 17.49 (-3.80%)
ARKG : 33.70 (-1.92%)
Navigating The Healthcare Industry: Science Fiction Turns to Reality

Kevin Cook joins us to help walk us through the maze that is the healthcare industry. We touch on everything from the hottest trends all the way down to how to pick a winning stock!

IBB : 116.88 (-2.19%)
XBI : 90.75 (-2.69%)
SBIO : 40.08 (-2.53%)
EW : 230.45 (-0.35%)
GWPH : 114.51 (-1.20%)
FOMX : 4.16 (-1.89%)
CRSP : 54.75 (-3.22%)
ARKG : 33.70 (-1.92%)
Tap Revenue Growth With These ETFs & Dump Earnings Recession

These sector ETFs could be played to highlight revenue growth in the third quarter.

EBAY : 35.36 (-0.70%)
PMR : 41.69 (-1.72%)
XLP : 63.59 (-0.69%)
XLF : 30.39 (-1.27%)
XLY : 125.95 (-1.39%)
XLU : 68.36 (+0.26%)
JWN : 38.67 (-1.70%)
TGT : 114.32 (-1.05%)
WMT : 114.37 (-1.24%)
KSS : 45.49 (-1.58%)
ARKG : 33.70 (-1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade ARKG with:

Fund Summary

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology,...

See More

Key Turning Points

2nd Resistance Point 35.21
1st Resistance Point 34.45
Last Price 33.70
1st Support Level 33.23
2nd Support Level 32.77

See More

52-Week High 36.63
Last Price 33.70
Fibonacci 61.8% 32.90
Fibonacci 50% 31.75
Fibonacci 38.2% 30.60
52-Week Low 26.87

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar